NRG GU-006 included the following as part of its eligibility criteria: “Persistent elevation of PSA after prostatectomy measured within 90 days after surgery (PSA never became undetectable) of >0.04 but <0.2 ng/mL (PSA nadir).” Is this your current approach? Does the presence of any PSA, even at lower values, impact your treatment recommendations?